InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
1
Disclosed sells
0
T+90 hit rate
75%
T+90 mean return
+15.6%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by STAAB THOMAS R II, Chief Financial Officer. Insider active across 3 companies, notably Tenax Therapeutics, INC.. Cumulatively, 14 reports have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €6k. Activity tracked since 11 January 2022. The latest transaction was disclosed on 11 May 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations14 total
10,000 shares0Common StockSEC:0001193125-26-221926
10,000 shares0Common StockSEC:0001193125-26-221926:0
12,766 shares0Common StockSEC:0000950170-25-024336:0
1,839 shares@ US$8.2540.0% of flowCommon StockSEC:0000950170-25-015541:0
3,500 shares@ US$2.6523.1% of flowCommon StockSEC:0000950170-24-095487:0
1,853 shares@ US$4.4320.3% of flowCommon StockSEC:0000950170-24-055774:0
6,656 shares0Common StockSEC:0000899243-23-001798:0
2,025 shares@ US$3.16216.6% of flowCommon StockSEC:0000899243-22-037965:0
Ideal exit: 2 Sept 2023 (T+270)
15,000 shares0Common StockSEC:0000899243-22-001924
15,000 shares0Common StockSEC:0000899243-22-001924:0
4,823 sharesCommon StockSEC:0001127602-16-037574:0
2,500 sharesCommon StockSEC:0001127602-16-037469:0
12,500 sharesCommon StockSEC:0001127602-16-037469:1
1,676 sharesCommon StockSEC:0001127602-16-035651:0
14 of 14 declarations
About STAAB THOMAS R II
Thomas R. Staab II is the Chief Financial Officer at Tenax Therapeutics, Inc. and LENSAR, Inc. He oversees the financial and strategic operations of both companies. His role is crucial in ensuring their financial health and supporting their growth in the market.
